Le principal objet de la présente assemblée est l'autorisation d'émettre 300 Obligations Convertibles en Actions de 20 000 € de nominal (soit au totale une émission de 6 M€ en nominal) au bénéfice d'une société de droit suisse, Nice & Green.
La société indique que cette opération s'inscrit dans s stratégie de renforcement des fonds propres. Si l’on comprend les raisons évoquées par la société, elle n’explique cependant pas pourquoi elle a choisi de faire une émission sans DPS au lieu d’une émission avec DPS à laquelle tous ses actionnaires actuels, confiants en la stratégie de la société, auraient pu participer. Réserver une telle part du capital (près de 50%) à 1 seul actionnaire semble particulièrement généreux et se fait au détriment des autres actionnaires qui vont, eux, se faire lourdement diluer.
Pour cette raison, mais aussi au regard du prix d'émission et de la possibilité d’usage en période d’offre publique, nous ne soutenons pas cette proposition.
Amoeba SA. Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.